PRAVITINIB Trademark

Trademark Overview

On Monday, September 14, 2015, a trademark application was filed for PRAVITINIB with the United States Patent and Trademark Office. The USPTO has given the PRAVITINIB trademark a serial number of 86755540. The federal status of this trademark filing is REGISTERED as of Tuesday, May 29, 2018. This trademark is owned by Tactical Therapeutics, Inc.. The PRAVITINIB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, inflammation and inflammatory diseases, auto-immune diseases, ophthalmic diseases, angiogenesis-dependent diseases, ocular angiogenic disease, diabetic retinopathy and macular degeneration made in whole or significant part of tyrosine kinase inhibitors
pravitinib

General Information

Serial Number86755540
Word MarkPRAVITINIB
Filing DateMonday, September 14, 2015
Status700 - REGISTERED
Status DateTuesday, May 29, 2018
Registration Number5481440
Registration DateTuesday, May 29, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, inflammation and inflammatory diseases, auto-immune diseases, ophthalmic diseases, angiogenesis-dependent diseases, ocular angiogenic disease, diabetic retinopathy and macular degeneration made in whole or significant part of tyrosine kinase inhibitors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 17, 2015
Primary Code005
First Use Anywhere DateTuesday, May 16, 2017
First Use In Commerce DateTuesday, May 16, 2017

Trademark Owner History

Party NameTactical Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10005
Party NameTactical Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10005
Party NameTactical Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10005

Trademark Events

Event DateEvent Description
Monday, May 29, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 29, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, April 26, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 25, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, April 8, 2018ASSIGNED TO LIE
Tuesday, March 27, 2018NOTICE OF REVIVAL - E-MAILED
Monday, March 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 26, 2018PETITION TO REVIVE-GRANTED
Monday, March 26, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, March 26, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, February 16, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 21, 2017NON-FINAL ACTION E-MAILED
Friday, July 21, 2017SU - NON-FINAL ACTION - WRITTEN
Saturday, July 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 1, 2017USE AMENDMENT FILED
Friday, June 30, 2017SOU EXTENSION 2 GRANTED
Wednesday, May 3, 2017SOU EXTENSION 2 FILED
Monday, June 26, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 2, 2017NOTICE OF REVIVAL - E-MAILED
Thursday, June 1, 2017EXTENSION RECEIVED WITH TEAS PETITION
Thursday, June 1, 2017PETITION TO REVIVE-GRANTED
Thursday, June 1, 2017TEAS PETITION TO REVIVE RECEIVED
Thursday, June 1, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, November 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2016SOU EXTENSION 1 GRANTED
Friday, October 28, 2016SOU EXTENSION 1 FILED
Friday, October 28, 2016TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 21, 2015EXAMINER'S AMENDMENT ENTERED
Monday, December 21, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 21, 2015EXAMINERS AMENDMENT E-MAILED
Monday, December 21, 2015EXAMINERS AMENDMENT -WRITTEN
Saturday, December 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 18, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 16, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 16, 2015NON-FINAL ACTION E-MAILED
Monday, November 16, 2015NON-FINAL ACTION WRITTEN
Wednesday, November 4, 2015ASSIGNED TO EXAMINER
Thursday, September 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 17, 2015NEW APPLICATION ENTERED

Related Keywords

pravitinib diseases degeneration made macular retinopathy disease diabetic whole kinase inhibitors